Polk D H, Ikegami M, Jobe A H, Sly P, Kohan R, Newnham J
Perinatal Research Laboratories, Harbor-University of California, Los Angeles, Medical Center, Torrance 90502, USA.
Am J Obstet Gynecol. 1997 Feb;176(2):308-15. doi: 10.1016/s0002-9378(97)70490-3.
We hypothesized that two doses of betamethasone administered 1 week apart would further enhance postnatal pulmonary function in preterm lambs (compared with a single dose).
Fetal sheep (121 days' gestation) randomly received saline solution or betamethasone (0.5 mg/kg) as a single injection. Six days later fetal sheep were retreated with either saline solution or corticosteroid, and postnatal lung function was evaluated 1 day later.
Betamethasone improved compliance and ventilation efficiency index nearly 50%, and total lung volume increased twofold. No effects of treatment-to-delivery interval (1 vs 7 days) or corticosteroid retreatment on pulmonary function were apparent. Although surfactant pool sizes increased as a function of duration of exposure, no additional effect of corticosteroid retreatment was noted. Antenatal betamethasone increased messenger ribonucleic acid levels for the surfactant proteins A and C, and retreatment augmented surfactant protein B messenger ribonucleic acid levels but suppressed surfactant protein A and C messenger ribonucleic acid.
Improved postnatal lung function resulting from antenatal betamethasone was not augmented by retreatment.
我们假设相隔1周给予两剂倍他米松会进一步增强早产羔羊出生后的肺功能(与单剂量相比)。
妊娠121天的胎羊随机接受生理盐水或倍他米松(0.5毫克/千克)单次注射。6天后,胎羊再次接受生理盐水或皮质类固醇注射,1天后评估出生后的肺功能。
倍他米松使顺应性和通气效率指数提高了近50%,肺总量增加了两倍。治疗至分娩间隔时间(1天与7天)或皮质类固醇再次治疗对肺功能无明显影响。尽管表面活性物质池大小随暴露时间增加而增加,但未观察到皮质类固醇再次治疗的额外作用。产前倍他米松增加了表面活性物质蛋白A和C的信使核糖核酸水平,再次治疗增加了表面活性物质蛋白B信使核糖核酸水平,但抑制了表面活性物质蛋白A和C信使核糖核酸水平。
产前倍他米松改善出生后肺功能的效果不会因再次治疗而增强。